Abstract
Global demand to rise 7.6% annually through 2011
The world market for enzymes will grow 7.6 percent per year to $6 billion in
2011, driven by continued robust growth in pharmaceutical enzyme demand,
doubledigit increases in demand for biocatalysts for pharmaceutical and other
fine chemical production, as well as the rapid expansion in bioethanol
production from grains.
Specialty enzyme markets offer good opportunities
Despite recent uncertainty in the important US pharmaceutical market, world
pharmaceutical enzyme demand will experience rapid advances going forward. As
was the case over the past decade, the primary growth drivers will be rapid
gains in both botulinum toxin-based neuromodulator and enzyme replacement
therapy (ERT) drugs, which will offset slower growth in digestive enzymes and
thrombolytics. The importance of biologically-derived chemicals will also be
apparent in the biocatalysts market as chemical and pharmaceutical companies
increasingly utilize these powerful enzymes to replace expensive precious
metal-based catalysts as they optimize specialty and fine chemical production.
Outside the specialty enzyme segment, US concern about that country' s
dependence on foreign oil will lead to extraordinary increases in federally
mandated use of grain-based ethanol in the gasoline pool, which will in turn
drive enzyme demand. Outside of North America, global warming concerns will
play a greater role in boosting grain-based ethanol production in Europe and
parts of the Asia/Pacific. However, despite significant investments in
research and development, biomass-based ethanol production will not
meaningfully contribute to enzyme demand until the longer term.
Study coverage
It presents historical demand data (1996, 2001 and 2006) plus forecasts for
2011 and 2016 by enzyme market, product, world region and for 43 countries.
The study also considers global market environment factors, evaluates company
market share data and profiles 43 competitors worldwide.
View Cart
